跳至主要内容
临床试验/IRCT20100414003706N43
IRCT20100414003706N43已完成3 期

Effect of probiotic administration to women at risk of preterm birth on some neonatal and maternal outcomes: a randomized controlled clinical trial

Tabriz University of Medical Sciences0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
17 years 至 45 years(—)
性别
Female

入选标准

  • Gestational age of 22 to 26 weeks based on ultrasound under 12 weeks or LMP
  • Being at risk of preterm birth, ie, having at least one of the following characteristics: history of preterm birth under 37 weeks or fetal loss after 16 weeks of pregnancy, cervical length less than 25 mm according to ultrasound results, twin, aged under 17 or over 35 years, cervical cerclage in the current pregnancy, smoking, less than 6 months interval between pregnancy and previous delivery, pre-pregnancy body mass index > 30 or < 18.5 kg/m2 and above, bacteriuria in the current pregnancy; or a history of hospitalization with symptoms/signs of threatened preterm birth, provided that suppression of the symptoms with tocolytic drugs (such as magnesium sulfate/nifedipine) in the current pregnancy.

排除标准

  • Pregnancy after in vitro fertilization
  • Premature rupture of membranes (PROM)
  • Known important medical problems such as chronic hypertension, diabetes, diseases of the thyroid or liver
  • Acute symptoms of premature labor
  • Known major fetal abnormalities
  • Known abnormalities of the woman uterus
  • Regular consumption of probiotics or having a history of sensitivity to probiotics
  • Drug or alcohol addiction
  • Triplets or more
  • Inflammatory bowel disease (as diagnosed by a specialist)
  • Participation in another trial

研究者

相似试验